Nephrogenic Systemic Fibrosis Lawsuit Scheduled For Trial in San Francisco
A date has been set for the start of what could be the first trial of a lawsuit involving nephrogenic systemic fibrosis (NSF), a severe and sometimes fatal condition caused…
Tag Archives: MRI Contrast Agent
-
-
Nephrogenic Systemic Fibrosis Risk 77 Times Higher Among Dialysis Patients
The results of a new study into side effects of gadolinium MRI contrast agents indicates that patients undergoing dialysis are at 77 fold higher risk of contracting nephrogenic systemic fibrosis…
-
Optimark MRI Contrast Agent NSF Warning Updated
The makers of Optimark, a gadolinium-based MRI contrasting agent, are changing the warning label to indicate that Optimark should not be used by patients with severe kidney problems. The label…
-
Nephrogenic Systemic Fibrosis Warnings to be Reviewed Again by FDA
An FDA advisory committee is planning to review a decision by the agency to place the same warning on all gadolinium-based MRI contrast agents about the risk of nephrogenic systemic…
-
Nephrogenic Systemic Fibrosis Settlements Being Negotiated on Bayer Magnevist Lawsuits
According to U.S. District Judge Dan Polster, Bayer Healthcare has initiated settlement negotiations with a number of plaintiffs who have filed Nephrogenic Systemic Fibrosis lawsuits after receiving the gadolinium-based Magnevist…
-
Gadolinium Litigation Judge May Not Preside Over First Trials
The federal judge overseeing the consolidated Gadolinium litigation involving cases filed on behalf of those who have developed Nephrogenic Systemic Fibrosis after receiving an MRI with contrast, has indicated that…
-
Gadolinium MRA Contrast Agent Approved by FDA with Warnings about Nephrogenic Systemic Fibrosis
The FDA has approved a new gadolinium-based contrast agent, Vasovist Injection, which is the first imaging agent approved for use during Magnetic Resonance Imaging (MRA) examinations.
-
Gadolinium Lawyers to Select from 193 NSF Lawsuits for First Trials
Lawyers for the plaintiffs and lawyers for the manufacturers of gadolinium based MRI contract agents, have filed a joint list of 193 NSF lawsuits which are eligible to be among…
-
Gadolinium Lawyers Set to Meet with Court about Product Identification and Trial Selection
Lawyers involved in the federal litigation over gadolinium-based contrast agents, which have been linked to the development of a debilitating condition known as Nephrogenic Systemic Fibrosis, are scheduled to meet…